SunAmerica
3
44M
3
0.03
2
- Areas of investment
Summary
SunAmerica is the famous Corporate Investor, which was founded in 1919. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Amarillo.
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the SunAmerica, startups are often financed by WaterView Partners, SunAmerica Ventures, Michael Fuchs. The meaningful sponsors for the fund in investment in the same round are Waterview Advisors, Venrock, TMCT Ventures. In the next rounds fund is usually obtained by UBM Plc, Sun Microsystems.
The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2007. This SunAmerica works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2000. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Film Production, Medical. Among the most popular portfolio startups of the fund, we may highlight AccessLine Communications, Creative Planet, Synta Pharmaceuticals. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.03
- Investments by industry
- Biotechnology (1)
- Health Care (1)
- Pharmaceutical (1)
- Medical (1)
- Telecommunications (1) Show 7 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2000
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 28
- Group Appearance index
- 1.00
- Avg. company exit year
- 24
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Synta Pharmaceuticals | 14 Jan 2004 | Biotechnology, Health Care, Medical, Pharmaceutical | Late Stage Venture | 50M | United States, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.